MU-PHE-HPHE-FMK, also known as N-Morpholineurea-phenylalanyl-homophenylalanylfluoromethyl ketone, is a synthetic peptidomimetic compound that functions as an inhibitor of cysteine proteases, including… Read more
MU-PHE-HPHE-FMK, also known as N-Morpholineurea-phenylalanyl-homophenylalanylfluoromethyl ketone, is a synthetic peptidomimetic compound that functions as an inhibitor of cysteine proteases, including calpain and cathepsins. In pharmaceutical research, this compound is utilized to investigate proteolytic pathways, particularly those involving cathepsin B and L, which are implicated in various pathological processes. Analytical laboratories rely on high-quality reference standards of this inhibitor to support critical processes such as impurity profiling, the identification of metabolic degradation products, and rigorous method validation. Additionally, stable isotope labelled versions of these molecules are essential for the high-precision quantification required during quality control and pharmacokinetic studies. By employing these specialized analytical tools, researchers can ensure the accuracy and reliability of their investigations into protease-mediated cellular mechanisms and the ongoing development of therapeutic inhibitors.